#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Precursor T-lymphoblastic lymphoma/leukaemia recurrent Systemic scleroderma Idiopathic pulmonary fibrosis Barth syndrome Nephropathy Plasma cell myeloma refractory Familial hypertriglyceridaemia Liver transplant rejection Retinopathy of prematurity Autoimmune haemolytic anaemia Ependymoma Vascular calcification Glycogen storage disease type I Frontotemporal dementia Neutropenia More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Trials in Disease Factor VIII deficiency – Diagnostics Prolymphocytic leukaemia – Basic Information Ehlers-Danlos syndrome Hereditary angioedema with C1 esterase inhibitor deficiency Chordoma – Life with Disease Acquired haemophilia – Life with Disease Osteosarcoma – Trials in Disease Mantle cell lymphoma stage III – Basic Information Factor IX deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Canagliflozin Adezunap Cobicistat PEGVISOMANT ZODASIRAN Gadobutrol HEMOPEXIN, HUMAN Diazepam Acemetacin L-Lysine Hydrochloride Lenvatinib ULTEVURSEN Efinopegdutide Feladilimab Eprosartan Mesilate Msv/As Petrelintide Paclitaxel Obaluronate Theophylline Methadone Hydrochloride More therapies…

    Learn about Your Condition

    Cutaneous lupus erythematosus Dry mouth Glomerulonephritis acute Procedural anxiety Liposarcoma metastatic Liposarcoma Dupuytren's contracture Acute kidney injury Hepatic angiosarcoma Pathogen resistance Liposarcoma recurrent Arterial stiffness Metastases to liver Haemophilia Lymphocytic lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Elranatamab
    • Bortezomib
    • Carfilzomib
    Belgium Croatia Czechia Denmark Finland France +10

  • Study Comparing Vedolizumab and Infliximab for Children Aged 6-17 with Ulcerative Colitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Infliximab
    • Vedolizumab
    Poland

  • Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Progressive relapsing multiple sclerosis
    • Secondary progressive multiple sclerosis
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Anhydrous Cholestyramine
    • Magnetic Resonance Imaging Contrast Media
    • Teriflunomide
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study on Lidocaine and Magnesium Sulfate for Patients Undergoing Lung Surgery with Video-Assisted Thoracic Surgery (VATS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary resection
    Investigated Drugs:
    • Magnesium Sulfate Heptahydrate
    • Lidocaine Hydrochloride
    • Sodium Chloride
    Spain

  • Study on the Effectiveness of Heated Chemotherapy with Mitomycin-C for Patients with Colon Cancer Spread to the Peritoneum After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    • Colorectal cancer
    Investigated Drugs:
    • Mitomycin
    Spain

  • Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Bulgaria Czechia France Germany Hungary Italy +5
Previous Page
1 … 479 480 481 482 483 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!